|
|
|
The 52nd Annual Meeting of the American Society of Hematology took place in Orlando, Florida December 4-7, 2010. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.
|
|
|
|
|
Michele Cavo, MD
Bologna University School of Medicine
Bologna Italy |
|
|
|
|
|
Michele Cavo, MD
Bologna University School of Medicine
Bologna Italy |
|
|
|
|
|
Antonio Palumbo, MD
University of Torino
Torino, Italy |
|
|
|
|
|
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota
USA |
|
|
|
|
|
Joan Bladé, MD
Hospital Clinic
Barcelona, Spain |
|
|
|
|
|
Andrzej J Jakubowiak, MD, PhD
University of Michigan
Ann Arbor, Michigan
USA
|
|
|
|
|
|
Meletios A. Dimopoulos, MD
Greek Myeloma Study Group
Greece
|
|
|
|
|
|
Irene M. Ghobrial, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
|
|
|
|
|
|
Irene Ghobrial, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
USA
|
|
|
|
|
|
Paul G. Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
USA
|
|
|
|
|
|
Philippe Moreau, MD
University Hospital
Nantes, France |
|
|
|
|
|
Jonathan L. Kaufman
Winship Cancer Institute of Emory University
Atlanta, Georgia
USA
|
|
|
|
|
|
Ruben Niesvizky, MD
Weill Cornell Medical College
New York, New York
USA
|
|
|
|
|
|
Ruben Niesvizky, MD
Weill Cornell Medical College
New York, New York
USA
|
|
|
|
|
back
print
back to top